Understanding Chronic Treatments by Patients Over 65 Years of Age
ConditionChronic Treatments
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age65+
SponsorUniversité de Reims Champagne-Ardenne
About this trial
The ageing of the French population is accompanied by an increase in the number of chronic conditions per person. In 2008, according to IRDES (Institute for Research and Documentation in Health Economics), the average number of reported illnesses was six for people over the age of 65.
This multi-morbidity is associated with polypharmacy, which is a recognised risk factor for poor treatment compliance.
One of the causes of poor compliance is a lack of understanding of the treatment. In this context, the role of the general practitioner is central. General practitioners are responsible for more than three-quarters of medical prescriptions. They are the ones who initiate first-line treatments for chronic diseases, but also the ones who renew treatments introduced by specialists.
Eligibility criteria
Qualifiers
Are aged 65 or over
Consulting one of the general practitioners agreeing to participate in the study
Have a prescription containing at least one chronic treatment (defined as a treatment lasting more than 3 months)
Agree to participate in the study.
Disqualifiers
Does not understand French,
Has neurocognitive disorders
Lives in a medical facility
Consulting for an acute condition and whose prescription does not include chronic treatment.
Trial design
Treatments tested in this trial
- data collection
Treatment groups
No treatment groups listed
Sponsors and collaborators
Source ClinicalTrials.gov